Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes.

Samojlik, Magdalena M; Stabler, Cherie L

Samojlik, Magdalena M; Stabler, Cherie L.

Afiliação

Samojlik MM; J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, USA.
Stabler CL; J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, USA; University of Florida Diabetes Institute, Gainesville, FL, USA; Graduate Program in Biomedical Sciences, College of Medicine, University of Florida, Gainesville, FL, USA. Electronic address: cstabler@bme.ufl.edu.

Acta Biomater ; 133: 87-101, 2021 10 01.

Article em En | MEDLINE | ID: mdl-34102338

Assuntos

Diabetes Mellitus Tipo 1; Transplante de Células-Tronco Hematopoéticas; Transplante das Ilhotas Pancreáticas; Autoimunidade; Materiais Biocompatíveis/farmacologia; Diabetes Mellitus Tipo 1/terapia; Humanos

Palavras-chave

Allograft; Autoimmunity; Drug delivery; Encapsulation; Immunomodulation; Islet transplantation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante das Ilhotas Pancreáticas / Transplante de Células-Tronco Hematopoéticas / Diabetes Mellitus Tipo 1 Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google